Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate.

Abstract:

:Recent genome analysis of human prostate cancers demonstrated that both AR gene amplification and TP53 mutation are among the most frequently observed alterations in advanced prostate cancer. However, the biological role of these dual genetic alterations in prostate tumorigenesis is largely unknown. In addition, there are no biologically relevant models that can be used to assess the molecular mechanisms for these genetic abnormalities. Here, we report a novel mouse model, in which elevated transgenic AR expression and Trp53 deletion occur simultaneously in mouse prostatic epithelium to mimic human prostate cancer cells. These compound mice developed an earlier onset of high-grade prostatic intraepithelial neoplasia and accelerated prostate tumors in comparison with mice harboring only the AR transgene. Histological analysis showed prostatic sarcomatoid and basaloid carcinomas with massive squamous differentiation in the above compound mice. RNA-sequencing analyses identified a robust enrichment of the signature genes for human prostatic basal cell carcinomas in the above prostate tumors. Master regulator analysis revealed SOX2 as a transcriptional regulator in prostatic basal cell tumors. Elevated expression of SOX2 and its downstream target genes were detected in prostatic tumors of the compound mice. Chromatin immunoprecipitation analyses implicate a coregulatory role of AR and SOX2 in the expression of prostatic basal cell signature genes. Our data demonstrate a critical role of SOX2 in prostate tumorigenesis and provide mechanistic insight into prostate tumor aggressiveness and progression mediated by aberrant AR and p53 signaling pathways.

journal_name

Oncogene

journal_title

Oncogene

authors

He Y,Johnson DT,Yang JS,Wu H,You S,Yoon J,Lee DH,Kim WK,Aldahl J,Le V,Hooker E,Yu EJ,Geradts J,Cardiff RD,Sun Z

doi

10.1038/s41388-019-0901-8

subject

Has Abstract

pub_date

2019-09-01 00:00:00

pages

6507-6520

issue

38

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-019-0901-8

journal_volume

38

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.

    abstract::For many years the precise genetic etiology of the majority of Wilms' tumors has remained unexplained. Recently, the WTX gene, mapped to chromosome Xq11.1, has been reported to be lost or mutated in approximately one-third of Wilms' tumors. Moreover, in female cases, the somatically inactivated alleles were found to i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.93

    authors: Perotti D,Gamba B,Sardella M,Spreafico F,Terenziani M,Collini P,Pession A,Nantron M,Fossati-Bellani F,Radice P

    更新日期:2008-07-31 00:00:00

  • FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.

    abstract::Understanding the molecular mechanisms that underlie the aggressive behavior and relapse of breast cancer may help in the development of novel therapeutic interventions. CUB-domain-containing protein 1 (CDCP1), a transmembrane adaptor protein, is highly maintained and required in the context of cellular metastatic pot...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0372-3

    authors: Cui YH,Kim H,Lee M,Yi JM,Kim RK,Uddin N,Yoo KC,Kang JH,Choi MY,Cha HJ,Kwon OS,Bae IH,Kim MJ,Kaushik N,Lee SJ

    更新日期:2018-10-01 00:00:00

  • Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers.

    abstract::Selective inhibition of BCL-2 is expected to enhance therapeutic vulnerability in luminal estrogen receptor-positive breast cancers. We show here that the BCL-2 dependency of luminal tumor cells is nevertheless mitigated by breast cancer-associated fibroblasts (bCAFs) in a manner that defines MCL-1 as another critical...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0635-z

    authors: Louault K,Bonneaud TL,Séveno C,Gomez-Bougie P,Nguyen F,Gautier F,Bourgeois N,Loussouarn D,Kerdraon O,Barillé-Nion S,Jézéquel P,Campone M,Amiot M,Juin PP,Souazé F

    更新日期:2019-04-01 00:00:00

  • HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.

    abstract::Growth factor receptor-mediated signal transduction has been implicated in conferring resistance to conventional chemotherapy on cancer cells. In this study, we delineated a pathway that involves HER2/PI-3K/Akt in mediating multidrug resistance in human breast cancer cells. We found that the cell lines that express bo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206394

    authors: Knuefermann C,Lu Y,Liu B,Jin W,Liang K,Wu L,Schmidt M,Mills GB,Mendelsohn J,Fan Z

    更新日期:2003-05-22 00:00:00

  • Inhibition of crystallin expression and induction of apoptosis by lens-specific E1A expression in transgenic mice.

    abstract::Previous studies have shown that the adenovirus E1A oncoprotein can bind to and inactivate the retinoblastoma tumor suppressor protein (pRb) and the transcriptional coactivators CBP/p300. In this study, wild-type E1A12S or two deletion mutants (delN, which binds pRb but not CBP/p300; delCR2, which binds to CBP/p300 bu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205050

    authors: Chen Q,Ash JD,Branton P,Fromm L,Overbeek PA

    更新日期:2002-02-07 00:00:00

  • Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation.

    abstract::cDNA clones of human fos-related genes fra-1 and fra-2 were isolated by screening human c-DNA libraries with human fos DNA as a probe. We obtained human fra-1 cDNA clones that can code for a protein of 271 amino acid residues with a calculated molecular weight of 29,413 and showed 90% similarity with rat fra-1 protein...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Matsui M,Tokuhara M,Konuma Y,Nomura N,Ishizaki R

    更新日期:1990-03-01 00:00:00

  • An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer.

    abstract::Poor-prognosis oestrogen receptor-positive breast cancer is characterised by the presence of high-level focal amplifications. We utilised a focused small interfering RNA screen in 14 breast cancer cell lines to define genes that were pathogenic in three genomic regions focally amplified in oestrogen receptor-positive ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.202

    authors: Garcia-Murillas I,Sharpe R,Pearson A,Campbell J,Natrajan R,Ashworth A,Turner NC

    更新日期:2014-05-08 00:00:00

  • A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways.

    abstract::Earlier we showed that RACK1 regulates growth of human colon cells by suppressing Src activity at G(1) and mitotic checkpoints. Here, we show that RACK1 also induces apoptosis of the cells, partly by inhibiting Src. In the intrinsic pathway, RACK1 inhibits expression of anti-apoptotic Bcl-2 and Bcl-X(L), induces expre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.293

    authors: Mamidipudi V,Cartwright CA

    更新日期:2009-12-17 00:00:00

  • The E-cadherin-repressed hNanos1 gene induces tumor cell invasion by upregulating MT1-MMP expression.

    abstract::In this study, we examined the role of the E-cadherin-repressed gene human Nanos1 (hNanos1) in tumor invasion process. First, our in vivo study revealed that hNanos1 mRNAs were overexpressed in invasive lung carcinomas. Moreover, hNanos1 was co-localized with MT1-MMP (membrane type 1-matrix metalloproteinase) in E-cad...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1211035

    authors: Bonnomet A,Polette M,Strumane K,Gilles C,Dalstein V,Kileztky C,Berx G,van Roy F,Birembaut P,Nawrocki-Raby B

    更新日期:2008-06-12 00:00:00

  • Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice.

    abstract::Pharmacological inactivation of cancer genes or products is being used as a strategy for therapy in oncology. To investigate the potential role of BCR-ABLp190 cessation in leukaemia development, we generated mice carrying a tetracycline-repressible BCR-ABLp190 transgene. These mice were morphologically normal at birth...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209968

    authors: Pérez-Caro M,Gutierrez-Cianca N,González-Herrero I,López-Hernández I,Flores T,Orfao A,Sánchez-Martín M,Gutiérrez-Adán A,Pintado B,Sánchez-García I

    更新日期:2007-03-15 00:00:00

  • G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells.

    abstract::Inhibition of telomerase activity by telomerase inhibitors induces a gradual loss of telomeres, and this in turn causes cancer cells to enter to a crisis stage. Here, we report the telomerase inhibitor telomestatin, which is known to stabilize G-quadruplex structures at 3' single-stranded telomeric overhangs (G-tails)...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209217

    authors: Tahara H,Shin-Ya K,Seimiya H,Yamada H,Tsuruo T,Ide T

    更新日期:2006-03-23 00:00:00

  • The Rafts of the Medusa: cholesterol targeting in cancer therapy.

    abstract::In this issue of Oncogene, Mollinedo and co-workers present promising evidence that cholesterol-sensitive signaling pathways involving lipid rafts can be therapeutically targeted in multiple myeloma. Because the pathways considered in their study are used by other types of tumor cells, one implication of this report i...

    journal_title:Oncogene

    pub_type: 评论,杂志文章

    doi:10.1038/onc.2010.132

    authors: Freeman MR,Di Vizio D,Solomon KR

    更新日期:2010-07-01 00:00:00

  • Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.

    abstract::There is an increasing interest in determining the role of ribosomal proteins (RPs) in the regulation of MDM2-p53 pathway in coordinating cellular response to stress. Herein, we report a novel regulatory role of ribosomal protein S25 (RPS25) in MDM2-mediated p53 degradation and a feedback regulation of S25 by p53. We ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.289

    authors: Zhang X,Wang W,Wang H,Wang MH,Xu W,Zhang R

    更新日期:2013-05-30 00:00:00

  • To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control.

    abstract::To ensure that their mRNAs are translated and that the viral proteins necessary for assembling the next generation of infectious progeny are produced, viruses must effectively seize control of the translational machinery within their host cells. In many cases, the ability to productively engage host translational comp...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209053

    authors: Mohr I

    更新日期:2005-11-21 00:00:00

  • Regulation of Laloo by the Xenopus C-terminal Src kinase (Xcsk) during early vertebrate development.

    abstract::Mesoderm formation in the frog, Xenopus laevis, is dependent on the activity of one or more members of the Src family kinases; the molecular interactions underlying this requirement are not well understood. The C-terminal Src Kinase (Csk) is a potent inhibitor of Src activity, and is required for normal mammalian deve...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204672

    authors: Song Y,Cohler AN,Weinstein DC

    更新日期:2001-08-23 00:00:00

  • Apc and p53 interaction in DNA damage and genomic instability in hepatocytes.

    abstract::Disruption of Apc (adenomatous polyposis coli) within hepatocytes activates Wnt signalling, perturbs differentiation and ultimately leads to neoplasia. Apc negatively regulates Wnt signalling but is also involved in organizing the cytoskeleton and may have a role in chromosome segregation. In vitro studies have implic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.342

    authors: Méniel V,Megges M,Young MA,Cole A,Sansom OJ,Clarke AR

    更新日期:2015-07-30 00:00:00

  • Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol.

    abstract::Radicicol, a macrocyclic anti-fungal antibiotic, has the ability to suppress transformation by diverse oncogenes such as Src, Ras and Mos. Despite this useful property, the mechanism by which radicicol exerts its anti-transformation effects is currently unknown. To understand the transformation-suppressing effects of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201790

    authors: Sharma SV,Agatsuma T,Nakano H

    更新日期:1998-05-01 00:00:00

  • Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.

    abstract::Individuals with germline mutations in the tumour-suppressor gene CYLD are at high risk of developing disfiguring cutaneous appendageal tumours, the defining tumour being the highly organised cylindroma. Here, we analysed CYLD mutant tumour genomes by array comparative genomic hybridisation and gene expression microar...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.133

    authors: Rajan N,Elliott R,Clewes O,Mackay A,Reis-Filho JS,Burn J,Langtry J,Sieber-Blum M,Lord CJ,Ashworth A

    更新日期:2011-10-13 00:00:00

  • How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

    abstract::Cancer cells enhance their glycolysis, producing lactate, even in the presence of oxygen. Glycolysis is a series of ten metabolic reactions catalysed by enzymes whose expression is most often increased in tumour cells. HKII and phosphoglucose isomerase (PGI) have mainly an antiapoptotic effect; PGI and glyceraldehyde-...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2014.320

    authors: Lincet H,Icard P

    更新日期:2015-07-01 00:00:00

  • Rho GTPases: Anti- or pro-neoplastic targets?

    abstract::Rho GTPases are critical signal transducers of multiple pathways. They have been proposed to be useful anti-neoplastic targets for over two decades, especially in Ras-driven cancers. Until recently, however, few in vivo studies had been carried out to test this premise. Several recent mouse model studies have verified...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.473

    authors: Zandvakili I,Lin Y,Morris JC,Zheng Y

    更新日期:2017-06-08 00:00:00

  • AP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formation.

    abstract::Activator protein one (AP1) (jun/fos) factors comprise a family of transcriptional regulators (c-jun, junB, junD, c-fos, FosB, Fra-1 and Fra-2) that are key controllers of epidermal keratinocyte survival and differentiation, and are important drivers of cancer development. Understanding the role of these factors in ep...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.315

    authors: Rorke EA,Adhikary G,Jans R,Crish JF,Eckert RL

    更新日期:2010-11-04 00:00:00

  • NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer.

    abstract::The transcription factor nuclear factor kappa B (NF-κB) and the long non-coding RNA (lncRNA) HOTAIR (HOX transcript antisense RNA) have diverse functional roles in cancer. In this study, we show that upregulation of HOTAIR induced platinum resistance in ovarian cancer, and increased HOTAIR levels were observed in recu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.75

    authors: Özeş AR,Miller DF,Özeş ON,Fang F,Liu Y,Matei D,Huang T,Nephew KP

    更新日期:2016-10-13 00:00:00

  • The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization.

    abstract::ASPP1 and ASPP2 are both proteins that interact with p53 and enhance its ability to induce apoptosis by selectively elevating the expression of proapoptotic p53-responsive genes. iASPP(RAI) is a third member of the family that is the most conserved inhibitor of p53-mediated apoptosis. Here, we have described iASPP, a ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208088

    authors: Slee EA,Gillotin S,Bergamaschi D,Royer C,Llanos S,Ali S,Jin B,Trigiante G,Lu X

    更新日期:2004-12-02 00:00:00

  • The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family.

    abstract::Apoptosis is essential for normal development and maintenance of homeostasis, and disruption of apoptotic pathways is associated with multiple disease states, including cancer. Although initially identified as central regulators of apoptosis at the level of mitochondria, an important role for BCL-2 proteins at the end...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2008.309

    authors: Heath-Engel HM,Chang NC,Shore GC

    更新日期:2008-10-27 00:00:00

  • The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.

    abstract::Hepatocellular carcinoma (HCC) metastasis is largely responsible for HCC-associated recurrence and mortality. We aimed to identify metastasis-related long non-coding RNAs (lncRNAs) to understand the molecular mechanism of HCC metastasis. We first identified that miR-1258 was downregulated in HCC tissues both in The Ca...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1307-3

    authors: Huang WJ,Tian XP,Bi SX,Zhang SR,He TS,Song LY,Yun JP,Zhou ZG,Yu RM,Li M

    更新日期:2020-06-01 00:00:00

  • Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.

    abstract::Prostate cancer is one of the major causes of cancer-related death in the western world. Androgen-deprivation therapy (ADT) for the suppression of androgens binding to the androgen receptor (AR) has been the norm of prostate cancer treatment. Despite early success to suppress prostate tumor growth, ADT eventually fail...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.121

    authors: Niu Y,Chang TM,Yeh S,Ma WL,Wang YZ,Chang C

    更新日期:2010-06-24 00:00:00

  • Loss of PTEN induces microtentacles through PI3K-independent activation of cofilin.

    abstract::Loss of PTEN tumor suppressor enhances metastatic risk in breast cancer, although the underlying mechanisms are poorly defined. We report that homozygous deletion of PTEN in mammary epithelial cells induces tubulin-based microtentacles (McTNs) that facilitate cell reattachment and homotypic aggregation. Treatment with...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.234

    authors: Vitolo MI,Boggs AE,Whipple RA,Yoon JR,Thompson K,Matrone MA,Cho EH,Balzer EM,Martin SS

    更新日期:2013-04-25 00:00:00

  • Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines.

    abstract::We have compared the DNase I hypersensitivity of the regulatory region of two estrogen-regulated genes, pS2 and cathepsin D in hormone-dependent and -independent breast carcinoma cell lines. This strategy allowed the identification of two important control regions, one in pS2 and the other in cathepsin D genes. In the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202317

    authors: Giamarchi C,Solanas M,Chailleux C,Augereau P,Vignon F,Rochefort H,Richard-Foy H

    更新日期:1999-01-14 00:00:00

  • The chicken Pdcd4 gene is regulated by v-Myb.

    abstract::The retroviral oncogene v-myb encodes a transcription factor (v-Myb) which is responsible for the ability of avian myeloblastosis virus (AMV) to transform myelomonocytic cells. v-Myb is thought to disrupt the differentiation of myelomonocytic cells by affecting the expression of specific target genes. To identify such...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204071

    authors: Schlichter U,Burk O,Worpenberg S,Klempnauer KH

    更新日期:2001-01-11 00:00:00

  • Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.

    abstract::Numerous reports suggest that use of nonsteroidal anti-inflammatory drugs (NSAIDs) decrease mortality from colorectal cancer. To better understand all of the mechanisms underlying this effect, the global pattern of gene expression in colon carcinoma cells following treatment with NS-398, a selective cyclo-oxygenase-2 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204588

    authors: Zhang Z,DuBois RN

    更新日期:2001-07-27 00:00:00